Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

4.5%

2 terminated/withdrawn out of 44 trials

Success Rate

89.5%

+3.0% vs industry average

Late-Stage Pipeline

2%

1 trials in Phase 3/4

Results Transparency

0%

0 of 17 completed trials have results

Key Signals

19 recruiting

Enrollment Performance

Analytics

N/A
7(58.3%)
Phase 1
2(16.7%)
Phase 2
2(16.7%)
Phase 4
1(8.3%)
12Total
N/A(7)
Phase 1(2)
Phase 2(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (44)

Showing 20 of 44 trials
NCT06186856Recruiting

Epidemiological Data on Mast Cell Pathologies in France

Role: lead

NCT02972281Not ApplicableCompleted

Systematic Search for Primary Immunodeficiency in Adults With Infections

Role: collaborator

NCT06660108Not ApplicableRecruiting

MOLECULAR BASIS OF LANGUAGE DEVELOPMENT AND ASSOCIATED DISORDERS

Role: collaborator

NCT07527624Recruiting

Evaluation of Socio-professional Inclusion for Young Adults Aged 15-25 Living With a Rare Genetic Disability

Role: lead

NCT06570278Not ApplicableRecruiting

Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes

Role: collaborator

NCT05564520Terminated

International Multicenter Study on Lipin-1 Deficiency

Role: lead

NCT06418243Recruiting

Contribution of 3D Modeling in Surgical Management of Pediatric Retroperitoneal and Pelvic Tumors

Role: collaborator

NCT05137873Completed

Measurement of the Prevalence of Sensory Integration Disorders in Babies Having Heart Disease Surgery for Transposition of the Great Vessels Before 6 Months of Age

Role: collaborator

NCT07432867Phase 1Recruiting

Efficacy Safety Study of Gene Therapy for Sickle Cell DiseaseSCD Using Autologous CD34+ Cells Transduced ex Vivo, Carrying a Corrected Globin Gene and a Silencing RNA.

Role: collaborator

NCT07422454Recruiting

FACE.S-4-KIDS : A Deep Phenotyping Database of Craniofacial Anomalies During Development With 4 Pilot Projects

Role: lead

NCT07040774Recruiting

Natural History of Type 1 Interferonopathies: Insights From a European Cohort

Role: lead

NCT06219421Recruiting

Automatic Phenotyping of Patients on 2D Photography

Role: lead

NCT07313098Not Yet Recruiting

Longitudinal Assessment of Protein Markers in the Cerebrospinal Fluid of Patients With Central Nervous System Involvement

Role: lead

NCT06235580Recruiting

Genotype-phenotype Characterization Study on Genetic Diseases With Immune and Neurological Dysfunctions

Role: lead

NCT06612333Completed

Evaluation of the French Version of the PEERS Social Skills Training Program for Adolescents With Rare Neurodevelopmental Disorders

Role: lead

NCT04280510Recruiting

Pathogenic Study of Adult Immune Enteropathies

Role: collaborator

NCT03562130Phase 4Completed

Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients

Role: collaborator

NCT06648044Not ApplicableRecruiting

Research of Therapeutic Targets in the Frame of Nephronophthisis and Renal Associated Ciliopathies

Role: lead

NCT06380192Recruiting

Developmental and Epileptic Encephalopathy of Genetic Etiology: Natural History Through Reuse of Clinical Data

Role: lead

NCT03194178Completed

Impact of Phonatory and Facial Morphology Disorders, on the Quality of Life of Adolescents With Pierre Robin Sequence

Role: lead